PRKAA1 and breast carcinoma: Consistent with this, PIAS4 knockdown in MDA-MD-231 breast cancer cells potentiated AMPK activity toward mTORC1 signalling and inhibited cell proliferation in response to the AMPK allosteric activator A769662.